ID

33103

Beschreibung

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00922649

Link

https://clinicaltrials.gov/show/NCT00922649

Stichworte

Versionen (1)
  1. 27.11.18 27.11.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

27. November 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Type 2 Diabetes NCT00922649

Englisch

Eligibility Type 2 Diabetes NCT00922649

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. is 18 to 75 years of age, inclusive;
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
2. has a clinical diagnosis of type 2 diabetes mellitus;
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
3. is anti-glutamic acid decarboxylase (gad) antibody negative;
Beschreibung

Anti-GAD antibody negative

Datentyp

boolean

Alias
UMLS CUI [1]
C1167898
4. has an a1c ≥ 7.0% and ≤ 10.5%;
Beschreibung

Hemoglobin A1c measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0474680
5. has a body mass index (bmi) ≥ 25 kg/m2 and ≤ 40 kg/m2;
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
6. is treated with either ≥ 2 oral antidiabetic agents (oa) or basal insulin ± oa(s) or basal-bolus insulin ± oa(s) for at least 3 months (subjects may also be treated with exenatide [byetta] or pramlintide [symlin].
Beschreibung

Antidiabetics Oral Quantity | Insulin Basal | Bolus Insulin Basal | exenatide | Byetta | Pramlintide | Symlin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C0021641
UMLS CUI [2,2]
C0205112
UMLS CUI [3,1]
C1705509
UMLS CUI [3,2]
C0021641
UMLS CUI [3,3]
C0205112
UMLS CUI [4]
C0167117
UMLS CUI [5]
C1636686
UMLS CUI [6]
C0537551
UMLS CUI [7]
C1174780
7. if on concomitant metformin, has serum creatinine < 1.5 mg/dl (male) or <1.4 mg/dl (female);
Beschreibung

Metformin | Creatinine measurement, serum | Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0025598
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0079399
8. if female, has a negative urine pregnancy test
Beschreibung

Gender Urine pregnancy test negative

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0430057
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. has experienced recurrent severe hypoglycemia (> 2 episodes) requiring assistance during the past 6 months;
Beschreibung

Recurrent severe hypoglycemia Episodes Quantity | Requirement Assistance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0342316
UMLS CUI [1,2]
C0332189
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C1269765
2. has clinical cardiovascular disease (cvd) as evidenced by prior myocardial infarction, stroke, arterial revascularization and/or angina with ischemic changes on ecg at rest, changes on graded exercise test, or positive cardiac imaging test results;
Beschreibung

Cardiovascular Disease | Myocardial Infarction | Cerebrovascular accident | Revascularization Arterial | Angina Pectoris With Resting ECG Changes Ischemic | Exercise test Changes | Cardiac imaging procedure Positive

Datentyp

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0038454
UMLS CUI [4,1]
C0581603
UMLS CUI [4,2]
C0221464
UMLS CUI [5,1]
C0002962
UMLS CUI [5,2]
C0332287
UMLS CUI [5,3]
C3897699
UMLS CUI [5,4]
C0475224
UMLS CUI [6,1]
C0015260
UMLS CUI [6,2]
C0392747
UMLS CUI [7,1]
C1096014
UMLS CUI [7,2]
C1514241
3. has abnormalities on the screening (visit 1) 12-lead ecg that are deemed by the investigator to be clinically significant;
Beschreibung

12 lead ECG Abnormality

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0430456
UMLS CUI [1,2]
C1704258
4. is currently being treated with or expected to require or undergo treatment with systemic steroids by oral, intravenous, or intramuscular route or potent inhaled,intrapulmonary, intranasal, or topical steroids that are known to have a high rate of systemic absorption;
Beschreibung

Systemic steroids Oral | Systemic steroids Intravenous | Systemic steroids Intramuscular | Inhaled steroids | Steroids Intrapulmonary | Steroids Intranasal | Topical steroids

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2825233
UMLS CUI [1,2]
C1527415
UMLS CUI [2,1]
C2825233
UMLS CUI [2,2]
C1522726
UMLS CUI [3,1]
C2825233
UMLS CUI [3,2]
C1556154
UMLS CUI [4]
C2065041
UMLS CUI [5,1]
C0038317
UMLS CUI [5,2]
C1522224
UMLS CUI [6,1]
C0038317
UMLS CUI [6,2]
C0001560
UMLS CUI [7]
C2064827
5. currently abuses drugs or alcohol or has a history of abuse that in the investigator's opinion would cause the individual to be non-compliant;
Beschreibung

Substance Use Disorders | Compliance behavior Lacking

Datentyp

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2,1]
C1321605
UMLS CUI [2,2]
C0332268
6. has any significant medical condition, laboratory findings, or medical history that in the investigator's opinion may affect successful completion of the study and/or personal well-being;
Beschreibung

Medical condition Affecting Completion of clinical trial | Laboratory finding Affecting Completion of clinical trial | Medical History Affecting Completion of clinical trial | Medical condition Affecting Personal Well-Being | Laboratory finding Affecting Personal Well-Being | Medical History Affecting Personal Well-Being

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2732579
UMLS CUI [2,1]
C0587081
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C2732579
UMLS CUI [3,1]
C0262926
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C2732579
UMLS CUI [4,1]
C3843040
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C1821407
UMLS CUI [5,1]
C0587081
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C1821407
UMLS CUI [6,1]
C0262926
UMLS CUI [6,2]
C0392760
UMLS CUI [6,3]
C1821407
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Type 2 Diabetes NCT00922649

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. is 18 to 75 years of age, inclusive;
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
2. has a clinical diagnosis of type 2 diabetes mellitus;
boolean
C0011860 (UMLS CUI [1])
Anti-GAD antibody negative
Item
3. is anti-glutamic acid decarboxylase (gad) antibody negative;
boolean
C1167898 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
4. has an a1c ≥ 7.0% and ≤ 10.5%;
boolean
C0474680 (UMLS CUI [1])
Body mass index
Item
5. has a body mass index (bmi) ≥ 25 kg/m2 and ≤ 40 kg/m2;
boolean
C1305855 (UMLS CUI [1])
Antidiabetics Oral Quantity | Insulin Basal | Bolus Insulin Basal | exenatide | Byetta | Pramlintide | Symlin
Item
6. is treated with either ≥ 2 oral antidiabetic agents (oa) or basal insulin ± oa(s) or basal-bolus insulin ± oa(s) for at least 3 months (subjects may also be treated with exenatide [byetta] or pramlintide [symlin].
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0021641 (UMLS CUI [2,1])
C0205112 (UMLS CUI [2,2])
C1705509 (UMLS CUI [3,1])
C0021641 (UMLS CUI [3,2])
C0205112 (UMLS CUI [3,3])
C0167117 (UMLS CUI [4])
C1636686 (UMLS CUI [5])
C0537551 (UMLS CUI [6])
C1174780 (UMLS CUI [7])
Metformin | Creatinine measurement, serum | Gender
Item
7. if on concomitant metformin, has serum creatinine < 1.5 mg/dl (male) or <1.4 mg/dl (female);
boolean
C0025598 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Gender Urine pregnancy test negative
Item
8. if female, has a negative urine pregnancy test
boolean
C0079399 (UMLS CUI [1,1])
C0430057 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Recurrent severe hypoglycemia Episodes Quantity | Requirement Assistance
Item
1. has experienced recurrent severe hypoglycemia (> 2 episodes) requiring assistance during the past 6 months;
boolean
C0342316 (UMLS CUI [1,1])
C0332189 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1514873 (UMLS CUI [2,1])
C1269765 (UMLS CUI [2,2])
Cardiovascular Disease | Myocardial Infarction | Cerebrovascular accident | Revascularization Arterial | Angina Pectoris With Resting ECG Changes Ischemic | Exercise test Changes | Cardiac imaging procedure Positive
Item
2. has clinical cardiovascular disease (cvd) as evidenced by prior myocardial infarction, stroke, arterial revascularization and/or angina with ischemic changes on ecg at rest, changes on graded exercise test, or positive cardiac imaging test results;
boolean
C0007222 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
C0581603 (UMLS CUI [4,1])
C0221464 (UMLS CUI [4,2])
C0002962 (UMLS CUI [5,1])
C0332287 (UMLS CUI [5,2])
C3897699 (UMLS CUI [5,3])
C0475224 (UMLS CUI [5,4])
C0015260 (UMLS CUI [6,1])
C0392747 (UMLS CUI [6,2])
C1096014 (UMLS CUI [7,1])
C1514241 (UMLS CUI [7,2])
12 lead ECG Abnormality
Item
3. has abnormalities on the screening (visit 1) 12-lead ecg that are deemed by the investigator to be clinically significant;
boolean
C0430456 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
Systemic steroids Oral | Systemic steroids Intravenous | Systemic steroids Intramuscular | Inhaled steroids | Steroids Intrapulmonary | Steroids Intranasal | Topical steroids
Item
4. is currently being treated with or expected to require or undergo treatment with systemic steroids by oral, intravenous, or intramuscular route or potent inhaled,intrapulmonary, intranasal, or topical steroids that are known to have a high rate of systemic absorption;
boolean
C2825233 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C2825233 (UMLS CUI [2,1])
C1522726 (UMLS CUI [2,2])
C2825233 (UMLS CUI [3,1])
C1556154 (UMLS CUI [3,2])
C2065041 (UMLS CUI [4])
C0038317 (UMLS CUI [5,1])
C1522224 (UMLS CUI [5,2])
C0038317 (UMLS CUI [6,1])
C0001560 (UMLS CUI [6,2])
C2064827 (UMLS CUI [7])
Substance Use Disorders | Compliance behavior Lacking
Item
5. currently abuses drugs or alcohol or has a history of abuse that in the investigator's opinion would cause the individual to be non-compliant;
boolean
C0038586 (UMLS CUI [1])
C1321605 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Medical condition Affecting Completion of clinical trial | Laboratory finding Affecting Completion of clinical trial | Medical History Affecting Completion of clinical trial | Medical condition Affecting Personal Well-Being | Laboratory finding Affecting Personal Well-Being | Medical History Affecting Personal Well-Being
Item
6. has any significant medical condition, laboratory findings, or medical history that in the investigator's opinion may affect successful completion of the study and/or personal well-being;
boolean
C3843040 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2732579 (UMLS CUI [1,3])
C0587081 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C2732579 (UMLS CUI [2,3])
C0262926 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C2732579 (UMLS CUI [3,3])
C3843040 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C1821407 (UMLS CUI [4,3])
C0587081 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C1821407 (UMLS CUI [5,3])
C0262926 (UMLS CUI [6,1])
C0392760 (UMLS CUI [6,2])
C1821407 (UMLS CUI [6,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video